CCM
WVE icon

Capstone Capital Management’s Wave Life Sciences WVE Stock Holding History

Capstone Capital Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$309K Sell
53,115
-90,914
-63% -$603K 0.14% 149
2026
Q1 		$1.04M Buy
+144,029
New +$1.88M 1.05% 23

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Capstone Capital Management's WVE Position: Q2 2026 in Review

Capstone Capital Management reduced its Wave Life Sciences (WVE) stake by 63% in Q2 2026, selling an estimated $603K and leaving 53,115 shares worth $309K. The position accounts for 0.14% of the portfolio, ranked #149.

Capstone Capital Management first reported a position in WVE in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.04M in Q1 2026. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Capstone Capital Management held 53,115 shares of Wave Life Sciences worth $309K as of Q2 2026.
  • Capstone Capital Management sold 90,914 Wave Life Sciences shares in Q2 2026, an estimated $603K.
  • Wave Life Sciences made up 0.14% of Capstone Capital Management's portfolio in Q2 2026, its #149 holding.
  • Capstone Capital Management first reported a position in Wave Life Sciences in Q1 2026 and has held it in 2 quarters since.
  • Capstone Capital Management's Wave Life Sciences position peaked at $1.04M in Q1 2026.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Capstone Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.